��ݮ��Ƶ

We will advance eye and vision care services by

• leveraging our expertise in ocular disease (glaucoma, diabetes and AMD), pediatrics, contact lens and low vision rehabilitation, and

• increasing patient access to specialized care in growing areas such as vision therapy, concussion, myopia control, and dry eye disease.

We will increase access to eye and vision care for communities across Canada by 

• creating a vital hub for diagnosing eye disease, and

• allowing patients in remote or under-serviced areas to receive care via teleoptometry technology.

The ��ݮ��Ƶ Eye Institute will build a paradigm that empowers optometrists to deliver a new level of patient care by

• creating a model of collaborative practice that can be replicated across Canada to improve access and efficiency in patient care.

• using telehealth technology to diagnose and connect patients with providers.

• training optometrists to the highest scope of practice in North America so they’re prepared to meet their patients’ needs, no matter where they practice.

• providing unique learning opportunities for students to work side-by-side with other health care professionals.

• expanding continuing professional development opportunities, so that all optometrists in Canada can expand and update their skills.

The ��ݮ��Ƶ Eye Institute will harness the University’s powerful research network to bring new techniques and treatments from the lab to the clinic and to enhance the delivery of patient care.

By embracing “the eye as the window to the brain,” we’ll create an ocular imaging research centre that builds on our expertise in eye-brain interaction. Through this centre, we will

• encourage collaboration among experts in imaging, artificial intelligence, vision science and brain health from across the University of ��ݮ��Ƶ and around the world.

• develop new tools for optometrists and other healthcare providers to diagnose, monitor and treat eye and brain conditions such as Parkinson’s, Alzheimer’s, diabetic retinopothy and genetic diseases.

• create new treatments for vision loss that focus on improving neural processing to potentially restore sight in patients with AMD, stroke and amblyopia.